Status:
COMPLETED
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
Lead Sponsor:
Pfizer
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It is possible to offer smoking cessation treatment including varenicline to patients scheduled for elective surgery. This study will evaluate whether or not this will enable some patients to quit smo...
Detailed Description
Recruitment to this study was terminated (on February 23, 2010) earlier than originally planned because recruitment was much slower than expected and therefore the study has already achieved its main ...
Eligibility Criteria
Inclusion
- Smokers motivated to stop smoking scheduled for elective surgery
Exclusion
- Current or recent depression
- Current or recent suicidal ideation
- Uncontrolled or unstable clinically significant medical condition
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00889720
Start Date
November 1 2009
End Date
July 1 2010
Last Update
October 17 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Paris, France, 75651
2
Pfizer Investigational Site
Pisa, Italy, 56124